Insider · CIK 0001560782

Daly James M

Reports to the SEC for 7 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001560782

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-01	HALOHALOZYME THERAPEUTICS, INC.A Award	Director	AAward	+1,169 sh	—	—	1,169
2026-10-01	HALOHALOZYME THERAPEUTICS, INC. · Option to Purchase Common StockA Award	Director	AAward	+1,775 sh	—	—	1,775
2026-07-15	CYTKCYTOKINETICS INCA Award	Director	AAward	+151 sh	$82.62	+$12.5K	3,390
2026-06-17	MDGLMADRIGAL PHARMACEUTICALS, INC.A Award	Director	AAward	+454 sh	—	—	3,081
2026-06-17	MDGLMADRIGAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+766 sh	—	—	766
2026-05-29	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−8,107 sh	—	—	0
2026-05-29	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+8,107 sh	—	—	12,148
2026-05-29	ACADACADIA PHARMACEUTICALS INC · Director Stock Options (Right to Buy)A Award	Director	AAward	+16K sh	—	—	16,004
2026-05-29	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	Director	AAward	+9,311 sh	—	—	9,311
2026-05-27	CYTKCYTOKINETICS INCA Award	Director	AAward	+2,851 sh	—	—	3,239
2026-05-27	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+4,301 sh	—	—	4,301
2026-04-15	CYTKCYTOKINETICS INCA Award	Director	AAward	+191 sh	$65.37	+$12.5K	388
2026-01-15	CYTKCYTOKINETICS INCA Award	Director	AAward	+197 sh	$63.44	+$12.5K	197
2025-11-10	ACADACADIA PHARMACEUTICALS INCS Sale	Director	SSale	−30K sh	$22.37	−$671K	4,041
2025-08-19	CYTKCYTOKINETICS INC · Non-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+27.5K sh	—	—	27,450
2025-06-20	MDGLMADRIGAL PHARMACEUTICALS, INC.A Award	Director	AAward	+715 sh	—	—	2,627
2025-06-20	MDGLMADRIGAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+1,290 sh	—	—	1,290
2025-05-29	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−9,387 sh	—	—	0
2025-05-29	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	Director	AAward	+8,107 sh	—	—	8,107
2025-05-29	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+9,387 sh	—	—	34,041
2025-05-29	ACADACADIA PHARMACEUTICALS INC · Director Stock Options (Right to Buy)A Award	Director	AAward	+13.8K sh	—	—	13,793
2025-02-27	MDGLMADRIGAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,000 sh	—	—	0
2025-02-27	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−398 sh	$346.90	−$138K	16,984
2025-02-27	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−14.3K sh	$347.39	−$4.97M	2,682
2025-02-27	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−770 sh	$348.94	−$269K	1,912
2025-02-27	MDGLMADRIGAL PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+9,470 sh	$65.06	+$616K	11,382
2025-02-27	MDGLMADRIGAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,470 sh	—	—	0
2025-02-27	MDGLMADRIGAL PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+6,000 sh	$111.06	+$666K	17,382
2024-06-25	MDGLMADRIGAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+1,105 sh	—	—	1,105
2024-06-25	MDGLMADRIGAL PHARMACEUTICALS, INC.A Award	Director	AAward	+714 sh	—	—	1,912
2024-05-29	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	Director	AAward	+9,387 sh	—	—	9,387
2024-05-29	ACADACADIA PHARMACEUTICALS INC · Director Stock Options (Right to Buy)A Award	Director	AAward	+16K sh	—	—	15,959
2024-05-29	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−6,652 sh	—	—	0
2024-05-29	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+6,652 sh	—	—	24,654
2024-04-02	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−557 sh	$246.30	−$137K	1,441
2024-04-02	MDGLMADRIGAL PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+10.9K sh	$105.08	+$1.15M	12,110
2024-04-02	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−200 sh	$248.45	−$49.7K	1,198
2024-04-02	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−43 sh	$247.03	−$10.6K	1,398
2024-04-02	MDGLMADRIGAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10.9K sh	—	—	0
2024-04-02	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−842 sh	$243.26	−$205K	11,268
2024-04-02	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−6,279 sh	$244.19	−$1.53M	4,989
2024-04-02	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−2,991 sh	$244.89	−$732K	1,998
2024-04-01	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−6,809 sh	$255.64	−$1.74M	15,966
2024-04-01	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−500 sh	$265.49	−$133K	1,472
2024-04-01	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,460 sh	$258.28	−$377K	3,501
2024-04-01	MDGLMADRIGAL PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$100.45	+$2.01M	21,198
2024-04-01	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−351 sh	$264.89	−$93K	1,972
2024-04-01	MDGLMADRIGAL PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,577 sh	$105.08	+$166K	22,775
2024-04-01	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−200 sh	$259.11	−$51.8K	3,301
2024-04-01	MDGLMADRIGAL PHARMACEUTICALS, INC.S Sale	Director	SSale	−274 sh	$266.91	−$73.1K	1,198

Recent filings

Accepted (ET)
Oct 24
Daly James M0001159036-26-000136
SEC(opens sec.gov)
Jul 164
Daly James M0001061983-26-000078
SEC(opens sec.gov)
Jun 184
Daly James M0001628280-26-044307
SEC(opens sec.gov)
Jun 14
Daly James M0001560782-26-000002
SEC(opens sec.gov)
May 274
Daly James M0001061983-26-000061
SEC(opens sec.gov)
Apr 154
Daly James M0001061983-26-000037
SEC(opens sec.gov)
Jan 204
Daly James M0001061983-26-000010
SEC(opens sec.gov)
Nov 124
Daly James M0001560782-25-000006
SEC(opens sec.gov)
Aug 204
Daly James M0001127602-25-020750
SEC(opens sec.gov)
Jun 244
Daly James M0001628280-25-032850
SEC(opens sec.gov)
Jun 24
Daly James M0001415889-25-015271
SEC(opens sec.gov)

Companies

Address

C/O HALOZYME THERAPEUTICS, INC. 12390 EL CAMINO REAL

SAN DIEGO, CA, 92130